Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does FUROSEMIDE Cause Diffuse large b-cell lymphoma refractory? 47 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 47 reports of Diffuse large b-cell lymphoma refractory have been filed in association with FUROSEMIDE (Furosemide). This represents 0.1% of all adverse event reports for FUROSEMIDE.

47
Reports of Diffuse large b-cell lymphoma refractory with FUROSEMIDE
0.1%
of all FUROSEMIDE reports
4
Deaths
47
Hospitalizations

How Dangerous Is Diffuse large b-cell lymphoma refractory From FUROSEMIDE?

Of the 47 reports, 4 (8.5%) resulted in death, 47 (100.0%) required hospitalization, and 4 (8.5%) were considered life-threatening.

Is Diffuse large b-cell lymphoma refractory Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for FUROSEMIDE. However, 47 reports have been filed with the FAERS database.

What Other Side Effects Does FUROSEMIDE Cause?

Acute kidney injury (7,984) Hypotension (4,468) Dyspnoea (3,559) Fall (3,410) Drug ineffective (3,297) Hyponatraemia (3,127) Hypokalaemia (2,503) Dehydration (2,195) Off label use (2,147) Fatigue (2,107)

What Other Drugs Cause Diffuse large b-cell lymphoma refractory?

RITUXIMAB (461) CYCLOPHOSPHAMIDE (360) DOXORUBICIN (345) VINCRISTINE (331) ETOPOSIDE (244) PREDNISONE (214) EPCORITAMAB-BYSP (198) CYTARABINE (193) DEXAMETHASONE (170) CISPLATIN (156)

Which FUROSEMIDE Alternatives Have Lower Diffuse large b-cell lymphoma refractory Risk?

FUROSEMIDE vs FUROSEMIDE\SPIRONOLACTONE FUROSEMIDE vs FUSIDATE FUROSEMIDE vs FUSIDIC ACID FUROSEMIDE vs FUTIBATINIB FUROSEMIDE vs GABAPENTIN

Related Pages

FUROSEMIDE Full Profile All Diffuse large b-cell lymphoma refractory Reports All Drugs Causing Diffuse large b-cell lymphoma refractory FUROSEMIDE Demographics